Showing results (21-30 of 299) with videos related to
Sort By:
Pageof 30
Clinical Immunology and Immunopathology|August 1, 1984
Human monoclonal antibodies to cytokeratins associated with squamous cell carcinomaJ W Pickering, R P MisraPlos One|April 30, 2013
Linking injury to outcome in acute kidney injury: a matter of sensitivityJohn W Pickering, Zoltan H EndreNature Reviews. Nephrology|January 29, 2014
Acute kidney injury: late-onset acute kidney injury-subacute or more of the same?Zoltán H Endre, John W PickeringPediatric Nephrology (Berlin, Germany)|May 29, 2012
Acute kidney injury clinical trial design: old problems, new strategiesZoltán H Endre, John W PickeringArzneimittel-Forschung|January 1, 1976
The protective effect of a novel compound RU 18492, on galactosamine-induced hepatotoxicity in the ratG W James, R W PickeringAmerican Journal of Physiology. Renal Physiology|July 29, 2016
Bench to bedside: the next steps for biomarkers in acute kidney injuryJohn W Pickering, Zoltan H EndreClinical Journal of the American Society of Nephrology : CJASN|June 9, 2012
New metrics for assessing diagnostic potential of candidate biomarkersJohn W Pickering, Zoltan H EndrePlos One|July 10, 2014
Acute kidney injury urinary biomarker time-coursesJohn W Pickering, Zoltán H EndreJournal of Immunology (Baltimore, Md. : 1950)|July 1, 1982
A human myeloma cell line that does not express immunoglobulin but yields a high frequency of antibody-secreting hybridomasJ W Pickering, F B GelderHealth Informatics Journal|June 16, 2018
Development of a digital clinical pathway for emergency medicine: Lessons from usability testing and implementation failureMarc Gutenstein, John W Pickering, Martin ThanPageof 30